insights_auto
Why is INO down 3,04%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,87 $
arrow_downward
-3,04%(-0,027) 1D
0,88 $
arrow_upward
+0,67% (+0,0058)bedtimeAfter hours
Closed: 26 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
0,92 $
High
0,94 $
Low
0,85 $
Mkt. cap
89,65 млн
Avg. vol.
3,56 млн
Volume
2,68 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
0,92 $
High
0,94 $
Low
0,85 $
Mkt. cap
89,65 млн
Avg. vol.
3,56 млн
Volume
2,68 млн
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
The Block
·
28 минут бұрын
CZ pitches BNB Chain’s role in AI as BNB Standard rings Nasdaq bell
TradingView
·
35 минут бұрын
Oppenheimer Names 16 Buys as S&P 500 Rally Stalls
The Globe and Mail
·
7 минут бұрын
American Analyst Updates: Oct 26th, 2026
Seeking Alpha
·
7 минут бұрын
3 things to look out for on Tuesday
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc